...
首页> 外文期刊>Antimicrobial agents and chemotherapy. >Mechanism of action of a novel series of naphthyridine-type ribosome inhibitors: enhancement of tRNA footprinting at the decoding site of 16S rRNA.
【24h】

Mechanism of action of a novel series of naphthyridine-type ribosome inhibitors: enhancement of tRNA footprinting at the decoding site of 16S rRNA.

机译:一系列新的萘啶型核糖体抑制剂的作用机制:增强16S rRNA解码位点处的tRNA足迹。

获取原文
获取原文并翻译 | 示例
           

摘要

The novel ribosome inhibitors (NRIs) are a broad-spectrum naphthyridine class that selectively inhibits bacterial protein synthesis (P. J. Dandliker et al., Antimicrob. Agents Chemother. 47:3831-3839, 2003). Footprinting experiments, using a range of NRIs and chemical modification agents on Escherichia coli ribosomes, revealed no evidence for direct protection of rRNA. In the presence of tRNA, however, we found that NRIs enhanced the known ribosomal footprinting pattern of tRNA in a dose-dependent manner. The most prominent increase in protection, at A1492/3 and A1413 in helix-44 of 16S RNA, strictly required the presence of tRNA and poly(U), and the effect was correlated with the potency of the inhibitor. Radioligand binding studies with inhibitor [(3)H]A-424902 showed that the compound binds to tRNA, either in its charged or uncharged form. The dissociation constant for [(3)H]A-424902 binding to Phe-tRNA(Phe) was determined to be 1.8 microM, near its translation inhibition potency of 1.6 muM in a cell-free S. pneumoniae extract assay. The compound did not change the binding of radiolabeled tRNA to the 30S ribosomal subunit. Taken together, these results imply that the NRIs exert their effects on protein synthesis by structurally perturbing the tRNA/30S complex at the decoding site.
机译:新型核糖体抑制剂(NRI)是选择性抑制细菌蛋白质合成的广谱萘啶类(P.J.Dandliker等人,Antimicrob.Agents Chemother.47:3831-3839,2003)。使用一系列NRI和化学修饰剂在大肠杆菌核糖体上进行的足迹实验表明,没有证据表明可以直接保护rRNA。但是,在存在tRNA的情况下,我们发现NRI以剂量依赖性方式增强了tRNA的已知核糖体足迹模式。保护的最显着增加是在16S RNA的helix-44中的A1492 / 3和A1413处,严格要求存在tRNA和poly(U),并且其作用与抑制剂的效力有关。用抑制剂[(3)H] A-424902进行的放射性配体结合研究表明,该化合物以带电或不带电的形式与tRNA结合。在无细胞肺炎链球菌提取物测定中,[(3)H] A-424902与Phe-tRNA(Phe)结合的解离常数确定为1.8 microM,接近其翻译抑制能力1.6μM。该化合物不会改变放射性标记的tRNA与30S核糖体亚基的结合。综上所述,这些结果暗示NRI通过在解码位点结构上干扰tRNA / 30S复合物而对蛋白质合成发挥作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号